Schizophrenia trials in China: A survey

A. Chakrabarti*, C. E. Adams, J. Rathbone, J. Wright, J. Xia, W. Wong, P. Von Reibnitz, C. Koenig, S. Baier, C. Pfeiffer, J. Blatter, M. Mantz, K. Kloeckner

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

8 Citations (Scopus)
28 Downloads (Pure)


Objective: China's biomedical research activity is increasing and this literature is becoming more accessible online. Our aim was to survey all randomized control schizophrenia trials (RCTs) in one Chinese bibliographic database. Method: Chinese Academic Journals was electronically searched for RCTs and all relevant citations were also sought on PubMed to ascertain global accessibility. Results: The search identified 3275 records, of which 982 were RCTs relevant to schizophrenia. A total of 71% (699) could be found by using English phrases. All the main body of text of the 982 papers was in Mandarin. On average, these trials involved about 100 people, with interventions and outcome measures familiar to schizophrenia trialists worldwide. Four of the 982 records (<1%) were identified on PubMed. Conclusion: Those undertaking systematic reviews should search the Chinese literature for relevant material. Failing to do this will leave the results of systematic reviews prone to random error or bias, or both.

Original languageEnglish
Pages (from-to)6-9
Number of pages4
JournalActa Psychiatrica Scandinavica
Issue number1
Publication statusPublished - Jul 2007
Externally publishedYes


Dive into the research topics of 'Schizophrenia trials in China: A survey'. Together they form a unique fingerprint.

Cite this